By Steve Hart
Research firm Zacks has rated Medtronic plc (NYSE:MDT) and has ranked it at 4, indicating that for the short term the shares are a sell. 19 Wall Street analysts have given the company an average rating of 1.66. The shares have received a hold rating based on the suggestion from 5 analysts in latest recommendations. Strong buy was given by 11 Wall Street Analysts. The shares had a buy rating from 3 analysts.
Many analysts have commented on the company rating. Brokerage firm BTIG Research upgrades its rating on Medtronic plc (NYSE:MDT). The shares have been rated Buy. Previously, the analysts had a Neutral rating on the shares. The rating by the firm was issued on July 16, 2015. 
Medtronic plc (NYSE:MDT): The stock price is expected to reach $ 86.75 in the short term. The number of analysts agreeing with this consensus is 12. The higher estimate for the short term price target is at $91 while the lower estimate is at $79. The standard deviation of the price stands at $4.11.